LUPPI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.205
EU - Europa 5.788
AS - Asia 1.102
SA - Sud America 56
OC - Oceania 7
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.170
IT - Italia 3.322
GB - Regno Unito 1.058
SE - Svezia 386
CN - Cina 372
SG - Singapore 314
DE - Germania 251
FR - Francia 186
UA - Ucraina 173
HK - Hong Kong 141
FI - Finlandia 114
TR - Turchia 100
RU - Federazione Russa 90
BG - Bulgaria 59
ID - Indonesia 43
NL - Olanda 43
BR - Brasile 33
IN - India 33
BE - Belgio 30
CA - Canada 27
IE - Irlanda 25
KR - Corea 16
JP - Giappone 15
IR - Iran 13
VN - Vietnam 12
LT - Lituania 10
AR - Argentina 8
ES - Italia 7
PL - Polonia 7
AU - Australia 6
CH - Svizzera 6
EU - Europa 6
MY - Malesia 6
CL - Cile 5
IQ - Iraq 5
MX - Messico 5
TW - Taiwan 5
BD - Bangladesh 4
LB - Libano 4
PE - Perù 4
AT - Austria 3
BZ - Belize 3
IL - Israele 3
NO - Norvegia 3
PK - Pakistan 3
CO - Colombia 2
CZ - Repubblica Ceca 2
HR - Croazia 2
LU - Lussemburgo 2
LV - Lettonia 2
PH - Filippine 2
RO - Romania 2
SA - Arabia Saudita 2
VE - Venezuela 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 13.170
Salva come PNG Salva come JPEG
Città #
Southend 887
Fairfield 792
Santa Clara 696
Chandler 478
Woodbridge 476
Ashburn 450
Houston 394
Ann Arbor 308
Seattle 269
Wilmington 260
Jacksonville 250
Cambridge 243
Dearborn 233
Milan 224
Nyköping 222
Rome 222
Singapore 219
Modena 145
Hong Kong 139
Beijing 98
San Diego 97
Helsinki 77
New York 77
Florence 67
Sofia 57
Princeton 56
Naples 55
Izmir 54
Eugene 52
Palermo 51
Catania 43
Bologna 41
Jakarta 41
London 41
Redwood City 40
Bari 35
Bremen 33
Shanghai 33
Brussels 28
Turin 28
Genoa 27
Padova 25
Boardman 24
Cagliari 23
Moscow 23
Verona 22
Mountain View 19
Falls Church 18
Salerno 18
Phoenix 16
Treviso 15
Bergamo 14
Brescia 14
Des Moines 14
Fremont 14
Los Angeles 14
Munich 14
Reggio Emilia 14
Guangzhou 13
Frankfurt am Main 12
Parma 12
Cinisello Balsamo 11
Norwalk 11
Torino 11
Toronto 11
Venice 11
Dong Ket 10
Reggio Calabria 10
Saint Petersburg 10
San Jose 10
Siena 10
Hefei 9
Leawood 9
Livorno 9
Messina 9
Nonantola 9
Perugia 9
Pescara 9
Pisa 9
Trieste 9
Chicago 8
Kunming 8
Monza 8
Novara 8
Atlanta 7
Cisterna di Latina 7
Falkenstein 7
Grafing 7
Latina 7
Nanjing 7
Seongnam-si 7
Trento 7
Altamura 6
Andover 6
Botucatu 6
Calgary 6
Caserta 6
Chennai 6
Desio 6
Indiana 6
Totale 8.698
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.246
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 370
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 280
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 274
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 261
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 253
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 252
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 239
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 238
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 237
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 236
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 226
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 225
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 225
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 217
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 213
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 212
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 210
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 207
Prognostic role of clusterin in resected adenocarcinomas of the lung. 206
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 206
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 199
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 197
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 195
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 193
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 193
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 192
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 191
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 184
Clusterin (CLU) and lung cancer. 182
Management of Idiopathic Pulmonary Fibrosis 178
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 177
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 176
Complex chronic co-morbidities of COPD 175
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 175
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 166
Treatment of chronic obstructive pulmonary disease and its comorbidities 158
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 156
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 153
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 152
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 144
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 143
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 139
Challenges in idiopathic interstitial lung disease 137
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 132
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 132
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 130
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 123
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 115
Therapeutic approaches to idiopathic pulmonary fibrosis 111
Malattie infiltrative diffuse del polmone 101
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 101
Medicina personalizzata e fibrosi polmonare idiopatica 88
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 86
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 80
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 65
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 50
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 22
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 4
Totale 13.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.731
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.151 0 0 0 0 0 0 327 256 232 130 133 73
2020/20211.757 170 63 129 170 170 148 129 200 91 218 147 122
2021/20221.458 86 116 113 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20242.061 115 139 156 199 270 224 201 225 60 95 174 203
2024/20251.811 198 112 115 263 593 432 98 0 0 0 0 0
Totale 13.328